메뉴 건너뛰기




Volumn 20, Issue 2, 2012, Pages 1100-1112

Design, synthesis and evaluation of polar head group containing 2-keto-oxazole inhibitors of FAAH

Author keywords

2 Keto oxazole; Endocannabinoid; FAAH inhibitor; Fatty acid amide hydrolase; Pain

Indexed keywords

1 [5 [2 [3 (DIMETHYLAMINO)PROPYLSULFONYL]ETHYL]OXAZOL 2 YL]DODECAN 1 ONE; 1 [5 [2 [3 (DIMETHYLAMINO)PROPYLSULFONYL]ETHYL]OXAZOL 2 YL]OCTAN 1 ONE; 1 [5 [2 [3 (DIMETHYLAMINO)PROPYLTHIO]ETHYL]OXAZOL 2 YL]DODECAN 1 ONE; 1 [5 [2 [3 (DIMETHYLAMINO)PROPYLTHIO]ETHYL]OXAZOL 2 YL]OCTAN 1 ONE; 1 [5 [3 [3 (DIMETHYLAMINO)PROPYLSULFONYL]PROPYL]OXAZOL 2 YL]DODECAN 1 ONE; 1 [5 [3 [3 (DIMETHYLAMINO)PROPYLSULFONYL]PROPYL]OXAZOL 2 YL]OCTAN 1 ONE; 1 [5 [3 [3 (DIMETHYLAMINO)PROPYLTHIO]PROPYL]OXAZOL 2 YL]DODECAN 1 ONE; 1 [5 [3 [3 (DIMETHYLAMINO)PROPYLTHIO]PROPYL]OXAZOL 2 YL]OCTAN 1 ONE; 1 [5 [4 [3 (DIMETHYLAMINO)PROPYLSULFONYL]BUTYL]OXAZOL 2 YL]DODECAN 1 ONE; 1 [5 [4 [3 (DIMETHYLAMINO)PROPYLSULFONYL]BUTYL]OXAZOL 2 YL]OCTAN 1 ONE; 1 [5 [4 [3 (DIMETHYLAMINO)PROPYLTHIO]BUTYL]OXAZOL 2 YL]DODECAN 1 ONE; 1 [5 [4 [3 (DIMETHYLAMINO)PROPYLTHIO]BUTYL]OXAZOL 2 YL]OCTAN 1 ONE; 1 [5 [5 [3 (DIMETHYLAMINO)PROPYLSULFONYL]PENTYL]OXAZOL 2 YL]DODECAN 1 ONE; 1 [5 [5 [3 (DIMETHYLAMINO)PROPYLSULFONYL]PENTYL]OXAZOL 2 YL]OCTAN 1 ONE; 1 [5 [5 [3 (DIMETHYLAMINO)PROPYLTHIO]PENTYL]OXAZOL 2 YL]DODECAN 1 ONE; 1 [5 [5 [3 (DIMETHYLAMINO)PROPYLTHIO]PENTYL]OXAZOL 2 YL]OCTAN 1 ONE; 1 [5 [6 [3 (DIMETHYLAMINO)PROPYLSULFONYL]HEXYL]OXAZOL 2 YL]DODECAN 1 ONE; 1 [5 [6 [3 (DIMETHYLAMINO)PROPYLTHIO]HEXYL]OXAZOL 2 YL]DODECAN 1 ONE; 1 [5 [6 [3 (DIMETHYLAMINO)PROPYLTHIO]HEXYL]OXAZOL 2 YL]OCTAN 1 ONE; FATTY ACID AMIDASE; FATTY ACID AMIDASE INHIBITOR; N METHOXY N METHYLDODECANAMIDE; N METHOXY N METHYLOCTANAMIDE; N,N DIMETHYL 3 [2 (OXAZOL 5 YL)ETHYLTHIO]PROPAN 1 AMINE; N,N DIMETHYL 3 [3 (OXAZOL 5 YL)PROPYLTHIO]PROPAN 1 AMINE; N,N DIMETHYL 3 [4 (OXAZOL 5 YL)BUTYLTHIO]PROPAN 1 AMINE; N,N DIMETHYL 3 [5 (OXAZOL 5 YL)PENTYLTHIO]PROPAN 1 AMINE; N,N DIMETHYL 3 [6 (OXAZOL 5 YL)HEXYLTHIO]PROPAN 1 AMINE; OXAZOLE DERIVATIVE; UNCLASSIFIED DRUG; UNINDEXED DRUG;

EID: 84855805087     PISSN: 09680896     EISSN: 14643391     Source Type: Journal    
DOI: 10.1016/j.bmc.2011.11.027     Document Type: Article
Times cited : (14)

References (34)


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.